Keyphrases
Interferon-α (IFN-α)
100%
Blood-brain Barrier
100%
West Nile Encephalitis
100%
Central Nervous System
100%
West Nile Virus
50%
West Nile Virus Infection
41%
Type I Interferon
41%
Immune Cell Trafficking
25%
Type I Interferon Signaling
16%
Leukocytes
16%
Neuroinvasion
16%
Central Nervous System Infections
16%
Viral Clearance
16%
Immunopathology
16%
Human Brain Microvascular Endothelial Cells (HBMEC)
16%
Antiviral Immune Response
16%
Viral Encephalitis
16%
Central Nervous Tissue
16%
Astrocytes
16%
Regulatory Effect
8%
Interferon Receptor
8%
Host Immune Response
8%
Endothelium
8%
Viral Pathogenesis
8%
Vulnerability
8%
Cytokine Signaling
8%
Virus
8%
Adaptive Immune Response
8%
Murine Model
8%
Tight Junction
8%
Limited Capacity
8%
Immune Infiltration
8%
Mosquito-borne Flavivirus
8%
Direct Antivirals
8%
Endothelial Cells
8%
Barrier Impact
8%
Immune Activation
8%
In Vitro Model
8%
Nervous-peripheral
8%
United States
8%
Barrier Integrity
8%
Bystander
8%
Immune Response
8%
Immune Damage
8%
Systemic Immune Response
8%
Infection Site
8%
Astrocyte Endfeet
8%
Endothelial Barrier Integrity
8%
Virus Trafficking
8%
Central Nervous System Autoimmunity
8%
Endothelial Barrier Function
8%
Pathogen Exposure
8%
West Nile
8%
Antiviral Cytokines
8%
Immune Cytokines
8%
Major Components
8%
Infected Leukocytes
8%
Innate Immune Response
8%
North America
8%
Peripheral Tissues
8%
Potential Pathogens
8%
Type I IFN
8%
Antiviral Activity
8%
Regulatory Role
8%
Anti-inflammatory Properties
8%
IFNAR1
8%
Immunology and Microbiology
interferon
100%
Encephalitis
100%
Blood Brain Barrier
100%
Central Nervous System
100%
West Nile Virus
64%
Immunity
35%
Infectious Agent
17%
Leukocyte
17%
Astrocyte
17%
Viral Encephalitis
11%
Immunopathology
11%
Viral Disease
11%
Viral Clearance
11%
Immune Response
5%
Tight Junction
5%
Immunocompetent Cell
5%
Antiviral Immune Response
5%
Antiviral Activity
5%
Cytokine Signaling
5%
Adaptive Immune System
5%
Autoimmunity
5%
Flavivirus
5%
Immune Cell Infiltration
5%
Interferon Family
5%
Cytokine
5%
Viral Pathogenesis
5%